A European lawyer argues that organisms derived from mutagenesis should be exempted from the rules applied to biotech organisms unless nucleic acid molecules or other biotech organisms have been inserted into them.
An offering of Series B convertible preferred stock was closed by Avinger, generating $18 million before discounts and expenses for use as working capital, as well as to support general corporate functions. The company added that in conjunction with the offering's closing, $38 million of debt has been converted by lenders under its term loan deal into Series A convertible preferred stock.
A round of equity financing brought in $118 million for Redwood City, Calif.-based surgical robotics company Procept BioRobotics. The proceeds will be used to support commercialization of the company's Aquablation therapy for minimally invasive benign prostatic hyperplasia treatment.
An additional $11 million was raised by Santa Clara, Calif.-based Cardiva Medical in a round of financing, bringing the total proceeds to $41 million. The company intends to use the money for continued commercialization of its Vascade vascular closure device.
A round of financing involving 19 unnamed investors brought in $9.8 million for Tewksbury, Mass.-based Mitralign. The company, which hopes to raise $30.2 million in the round, aims to seek regulatory approvals for its Trialign tricuspid valve device and market its namesake mitral valve treatment.
NuVasive's data collection and quality improvement tool for spine practices, SpineTRACK Registry, has been designated by the CMS as a qualified clinical data registry for the Merit-based Incentive Payment System.
Additional implants for the Proficient Posterior Cervical Spine System, including rod-to-rod connectors, screw-to-rod lateral connectors and smooth shank screws as an alternative for fixation, were released by Spine Wave. The system now comes with a translation screw to facilitate rod placement in posterior cervical-thoracic fixation procedures with medial-to-lateral translation.
The clinically validated machine-learning app of Palo Alto, Calif.-based Cognoa for pediatric behavioral health was categorized by the FDA as a Class II diagnostic medical device for autism. The app, which can detect autism in children as young as a year and a half, assesses child development and behavioral health through the analysis of parent-provided data and videos showing a child's natural behavior.
Cryptocurrency moguls are investing heavily in researching ways to extend human longevity. Among the recent donations is a gift of $2.4 million in the digital currency ether from Vitalik Buterin, the founder of Ethereum, to SENS Research, which is studying ways to treat the diseases of aging as well as methods of rejuvenation.
Yellow fever activity has been reported in seven countries in South America -- Bolivia, Brazil, Colombia, Ecuador, French Guiana, Peru and Suriname -- during the past two years. Brazil has recorded the most cases, and only Brazil and Peru have had cases of the illness this year.